Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is -17.51% vs 28.60% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -685.84% vs 93.52% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is -57.61% vs 135.28% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 6.13% vs -7.00% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of Piramal Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is -17.51% vs 28.60% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 17.39% vs -0.89% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -685.84% vs 93.52% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 15.07% vs 7.83% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -57.61% vs 135.28% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 82.94% vs -47.82% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 6.13% vs -7.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 2.24% vs -19.46% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






